- PackSize
- 50ug/100ug
- Target
- GLP-1 receptor
- Reactivity
- Human
- Applications
- ELISA, Functional assay, Research in vivo
- Host Species
- --
- Isotype
- Biosynthetic peptide.
- Conjugate/Modification
- --
- Recommended Dilution Ratio
- --
- Composition
- 0.01M PBS, pH 7.4.
- Purification Process
- Purified by HPLC.
- Purity
- >95% as determined by HPLC.
- storageCondition
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
- Clonality
- --
- Clone Number
- --
- Immunogen
- --
- Alias
- GLP-1 receptor, Glucagon-like peptide 1 receptor, GLP1R, GLP-1-R, GLP-1R, Gastric inhibitory polypeptide receptor, GIPR, GIP-R, Glucose-dependent insulinotropic polypeptide receptor, GCGR, Glucagon receptor, GL-R
- Species
- --
- Gene ID-1
- P43220 & P48546 & P47871
- Uniprot
- --
- Background
- Retatrutide is an investigational triple-hormone receptor agonist developed by Eli Lilly and Company, targeting the receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon. This unique mechanism aims to address metabolic disorders such as obesity, type 2 diabetes, and non-alcoholic steatohepatitis (NASH).<br>
- Tissue Expression
- --
- Signaling_pathway
- --
- Research Areas
- --